組織切片市場規模、佔有率及成長分析（按產品、技術、材料類型、應用、最終用途和地區）－2025-2032 年產業預測

預計到 2023 年全球組織切片市場規模將達到 5.9486 億美元，從 2024 年的 6.591 億美元成長到 2032 年的 14.9718 億美元，預測期內（2025-2032 年）的複合年成長率為 10.8%。

組織切片市場對醫療保健和生命科學至關重要，促進了研究、診斷和治療策略的進步。主要趨勢表明，受癌症和神經系統疾病等慢性疾病盛行率上升的推動，經濟成長強勁。組織切片可以詳細檢查薄組織樣本，以支持組織病理學和分子生物學應用，這對於了解疾病進展和評估治療效果至關重要。技術創新，尤其是自動化高通量系統的創新，正在提高準確性和效率，並最大限度地減少潛在的診斷錯誤。此外，隨著個人化醫療和精準診斷的需求不斷成長，精確的組織分析變得越來越重要，組織切片在製定客製化治療計劃和改善患者預後方面發揮著至關重要的作用。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管格局
• 專利分析

組織切片製備市場規模（依產品分類）

• 市場概覽
• 裝置
  • 旋轉切片機
  • 滑動切片機
  • 超薄切片機
  • 低溫恒溫器
  • 其他
• 配件和耗材
• 服務

組織切片市場規模（依技術分類）

• 市場概覽
• 自動的
• 半自動
• 手動的

組織切片市場規模（依材料類型）

• 市場概覽
• 聚甲醛
• OCT化合物
• 福馬林
• 包埋介質

組織切片市場規模（按應用）

• 市場概覽
• 診斷
• 調查

組織切片市場規模（依最終用途分類）

• 市場概覽
• 醫院
• 診所
• 診斷實驗室
• 研究中心

組織切片製備市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Thermo Fisher Scientific Inc.（USA）
• Leica Biosystems（USA）
• Sakura Finetek USA, Inc.（USA）
• Agilent Technologies, Inc.（USA）
• Merck KGaA（Germany）
• Roche Diagnostics（Switzerland）
• CellPath Ltd（UK）
• Gilson Incorporated（USA）
• RMC Boeckeler（USA）
• SLEE medical GmbH（Germany）
• MEDITE GmbH（Germany）
• Jinhua YIDI Medical Appliance Co., Ltd.（China）
• Diapath SpA（Italy）
• Hacker Instruments & Industries Inc.（USA）
• Bright Instrument Company td（UK）
• Boeckel+Co（GmbH+Co）KG（Germany）
• MICROS Produktions-und Handelsgesellschaft mbH（Austria）
• Nanolytik GmbH（Germany）
• Microservice Srl（Italy）
• Screen Holdings Co., Ltd.（Japan）

結論和建議

Global Tissue Sectioning Market size was valued at USD 594.86 million in 2023 and is poised to grow from USD 659.1 million in 2024 to USD 1497.18 million by 2032, growing at a CAGR of 10.8% during the forecast period (2025-2032).

The Tissue Sectioning Market is crucial to healthcare and life sciences, driving advancements in research, diagnostics, and treatment strategies. Key trends indicate robust growth, primarily fueled by the rising incidence of chronic diseases, including cancer and neurological disorders. Tissue sectioning enables detailed examination of thin tissue samples, supporting applications in histopathology and molecular biology, vital for understanding disease progression and evaluating treatment efficacy. Technological innovations, particularly in automated and high-throughput systems, are enhancing accuracy and efficiency, minimizing potential diagnostic errors. Moreover, as the demand for personalized medicine and precision diagnostics grows, the importance of precise tissue analysis escalates, solidifying tissue sectioning's integral role in developing tailored treatment plans and improving patient care outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Tissue Sectioning market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Tissue Sectioning Market Segments Analysis

Global Tissue Sectioning Market is segmented by Product, Technology, Material Type, Application, End-Use and region. Based on Product, the market is segmented into Instruments, Accessories & Consumables and Services. Based on Technology, the market is segmented into Automatic, Semiautomatic and Manual. Based on Material Type, the market is segmented into Paraformaldehyde, OCT Compound, Formalin and Embedding Media. Based on Application, the market is segmented into Diagnosis and Research. Based on End-Use, the market is segmented into Hospitals, Clinics, Diagnostic Laboratories and Research Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Tissue Sectioning Market

The increasing incidence of chronic illnesses, including cancer, cardiovascular diseases, and neurological disorders, has emerged as a major catalyst for the growth of the global tissue sectioning market. This essential technique in pathology and research plays a vital role in the diagnosis and comprehension of these medical conditions. With an aging global population and a corresponding rise in the prevalence of chronic diseases, there is a surging demand for tissue sectioning tools and services. Consequently, the tissue sectioning market is experiencing substantial growth, driven by the urgent need for precise diagnostic methods to address these health challenges.

Restraints in the Global Tissue Sectioning Market

The Global Tissue Sectioning market faces notable constraints primarily due to the high costs associated with advanced automated tissue sectioning equipment. This financial burden can deter smaller laboratories, clinics, and research institutions that operate on tight budgets from investing in such technology. The substantial initial expenses related to both the purchase and maintenance of these advanced systems can obstruct their widespread adoption, particularly in environments with limited financial resources. Consequently, the financial barriers presented by the pricing of tissue sectioning equipment may hinder technological advancements and limit access to quality tissue sectioning solutions in various healthcare and research settings.

Market Trends of the Global Tissue Sectioning Market

The Global Tissue Sectioning market is witnessing a transformative shift driven by the automation and digitization of tissue sectioning processes. Automated equipment, including advanced microtomes and cryostats, significantly enhances workflow efficiency and precision, thereby minimizing cross-contamination risks. This increase in automation is complemented by a notable trend towards digitizing tissue samples, fostering improved storage, analysis, and interoperability among pathology laboratories. The rise of digital pathology systems, integrated with sophisticated image analysis software, is making it easier for researchers and clinicians to access and interpret tissue data, ultimately propelling advancements in diagnostics and personalized medicine within a fast-evolving marketplace.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Patent Analysis

Global Tissue Sectioning Market Size by Product & CAGR (2025-2032)

• Market Overview
• Instruments
  • Rotary Microtome
  • Sliding Microtome
  • Ultramicrotome
  • Cryostat
  • Others
• Accessories & Consumables
• Services

Global Tissue Sectioning Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Automatic
• Semiautomatic
• Manual

Global Tissue Sectioning Market Size by Material Type & CAGR (2025-2032)

• Market Overview
• Paraformaldehyde
• OCT Compound
• Formalin
• Embedding Media

Global Tissue Sectioning Market Size by Application & CAGR (2025-2032)

• Market Overview
• Diagnosis
• Research

Global Tissue Sectioning Market Size by End-Use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Clinics
• Diagnostic Laboratories
• Research Centers

Global Tissue Sectioning Market Size & CAGR (2025-2032)

• North America (Product, Technology, Material Type, Application, End-Use)
  • US
  • Canada
• Europe (Product, Technology, Material Type, Application, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Material Type, Application, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Material Type, Application, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Material Type, Application, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Leica Biosystems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sakura Finetek USA, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CellPath Ltd (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilson Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RMC Boeckeler (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SLEE medical GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MEDITE GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jinhua YIDI Medical Appliance Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diapath S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hacker Instruments & Industries Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bright Instrument Company td (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boeckel + Co (GmbH + Co) KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MICROS Produktions- und Handelsgesellschaft m.b.H (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nanolytik GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microservice S.r.l. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Screen Holdings Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations